Integrating Artificial Intelligence with Liposomal Nanocarriers for Advanced Drug Delivery.

Pravin Kumar, Sunny Bhardwaj, Ajay Kumar, Tarun Kumar Sharma, Dev Raj Sharma, Mahendra Singh Ashawat, Ankit Sharma
{"title":"Integrating Artificial Intelligence with Liposomal Nanocarriers for Advanced Drug Delivery.","authors":"Pravin Kumar, Sunny Bhardwaj, Ajay Kumar, Tarun Kumar Sharma, Dev Raj Sharma, Mahendra Singh Ashawat, Ankit Sharma","doi":"10.2174/0126673878475998260827065237","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Liposomal drug delivery systems have achieved notable clinical success; however, their wider translation is often limited by complex formulation variables, unpredictable process behavior, and scalability challenges. Traditional trial-and-error optimization strategies struggle to address the nonlinear relationships that govern liposome quality, performance, and reproducibility. Recent advances in Artificial Intelligence (AI) and Machine Learning (ML) offer promising alternatives by enabling data-driven formulation design and process understanding.</p><p><strong>Methods: </strong>This review critically evaluates peer-reviewed studies published over the past decade that report the application of AI and ML in liposomal formulation development, microfluidic manufacturing, quality attribute prediction, and therapeutic performance assessment. Emphasis was placed on studies integrating computational models with experimental and advanced manufacturing workflows.</p><p><strong>Results: </strong>The reviewed literature demonstrates that AI-based models, including neural networks, deep learning architectures, and ensemble approaches, consistently outperform conventional statistical tools in predicting critical quality attributes such as particle size, polydispersity index, drug entrapment efficiency, stability, and release behavior. Integration of AI with microfluidic platforms further enables real-time process monitoring, improved reproducibility, and continuous manufacturing.</p><p><strong>Discussion: </strong>These findings highlight AI as a powerful framework for capturing complex relationships among formulation, process, and performance. Beyond optimization, AI facilitates deeper mechanistic understanding and supports predictive control strategies for liposomal systems.</p><p><strong>Conclusion: </strong>AI-integrated approaches represent a paradigm shift in liposome development, offering accelerated formulation design, enhanced scalability, and improved prospects for reliable clinical translation.</p>","PeriodicalId":94352,"journal":{"name":"Recent advances in drug delivery and formulation","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Recent advances in drug delivery and formulation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0126673878475998260827065237","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Liposomal drug delivery systems have achieved notable clinical success; however, their wider translation is often limited by complex formulation variables, unpredictable process behavior, and scalability challenges. Traditional trial-and-error optimization strategies struggle to address the nonlinear relationships that govern liposome quality, performance, and reproducibility. Recent advances in Artificial Intelligence (AI) and Machine Learning (ML) offer promising alternatives by enabling data-driven formulation design and process understanding.

Methods: This review critically evaluates peer-reviewed studies published over the past decade that report the application of AI and ML in liposomal formulation development, microfluidic manufacturing, quality attribute prediction, and therapeutic performance assessment. Emphasis was placed on studies integrating computational models with experimental and advanced manufacturing workflows.

Results: The reviewed literature demonstrates that AI-based models, including neural networks, deep learning architectures, and ensemble approaches, consistently outperform conventional statistical tools in predicting critical quality attributes such as particle size, polydispersity index, drug entrapment efficiency, stability, and release behavior. Integration of AI with microfluidic platforms further enables real-time process monitoring, improved reproducibility, and continuous manufacturing.

Discussion: These findings highlight AI as a powerful framework for capturing complex relationships among formulation, process, and performance. Beyond optimization, AI facilitates deeper mechanistic understanding and supports predictive control strategies for liposomal systems.

Conclusion: AI-integrated approaches represent a paradigm shift in liposome development, offering accelerated formulation design, enhanced scalability, and improved prospects for reliable clinical translation.

将人工智能与纳米脂质体相结合用于先进的药物递送。
介绍:脂质体给药系统已取得显著的临床成功;然而,它们的广泛转换通常受到复杂的公式变量、不可预测的过程行为和可伸缩性挑战的限制。传统的试错优化策略难以解决控制脂质体质量、性能和可重复性的非线性关系。人工智能(AI)和机器学习(ML)的最新进展通过实现数据驱动的配方设计和过程理解,提供了有希望的替代方案。方法:本综述对过去十年发表的同行评议研究进行了批判性评价,这些研究报告了AI和ML在脂质体配方开发、微流体制造、质量属性预测和治疗效果评估中的应用。重点放在将计算模型与实验和先进制造工作流程相结合的研究上。结果:综述的文献表明,基于人工智能的模型,包括神经网络、深度学习架构和集成方法,在预测关键质量属性(如粒径、多分散性指数、药物包裹效率、稳定性和释放行为)方面始终优于传统的统计工具。人工智能与微流控平台的集成进一步实现了实时过程监控,提高了再现性和连续制造。讨论:这些发现强调了人工智能作为捕获配方、过程和性能之间复杂关系的强大框架。除了优化,人工智能促进了更深层次的机制理解,并支持脂质体系统的预测控制策略。结论:人工智能集成方法代表了脂质体开发的范式转变,加速了配方设计,增强了可扩展性,并改善了可靠临床转化的前景。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书